Why Moderna (MRNA) Stock Fell 3.5% on November 13, 2026
-3.50%$223.26November 13, 2026 · S&P 500 -0.36%
The short answer
Moderna (MRNA) stock is down 3.5% in the November 13, 2026, session, trading at 223.26. This decline is much larger than the broader market, as the S&P 500 ETF (SPY) is down only 0.4%, indicating that the movement is primarily specific to MRNA or its industry. A possible reason for this decline may be linked to recent reports about Moderna issuing a cost outlook amid revenue uncertainty, which has contributed to investor concerns and led to the stock's drop.
The news behind it
Moderna Issues Cost Outlook Amid Revenue Uncertainty, Stock Falls · Yahoo · Nov 13
Before you buy or sell
Get a second opinion on MRNA
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when MRNA moves
Price, RSI and volume alerts by email or push. Free plan →
Full market recap for November 13, 2026 · What's moving MRNA today
Written from that session's quote and the headlines listed above. Educational, not financial advice.